$ StockFuze $

[TyTrades]

CannaSector Watchlist:

$FITX and $EDXC about to make history IMO

My two favorite Cannabis Sector Stocks with huge upside potential.

[TyTrades]

$NNAN - Blue sky breakout just started Friday!

Huge upside potential with no resistance levels in sight IMO

100% BUY - Short, Medium, and Longterm @ Barchart.com:

http://www.barchart.com/opinions/stocks/NNAN

Patents and Nanotechnology

Looks like a winner here with a no compensation BIG Investment Alert announced today.

[Mungyboy]

Take a look at $ YIPI tomorrow ! :)

[recinvestor]

Huge news! EDXC enters definitive agreement to acquire THC Finder!

http://online.wsj.com/article/PR-CO-20130928-901691.html

Stockfuze family is supporting this one big time!
Rec

[TyTrades]

$EDXC - Heavy Volume and Accumulation!
6M Daily Chart: http://scharts.co/1csdV9Z

HUGE spike in CMF indicating serious accumulation, closing green on the HEAVIEST volume since June 1st.

Endexx Corp announced a "Definitive" (Not yet completed) Agreement, May 30, 2013, to acquire Dispense Labs LLC, owner of AutoSpense. This acquisition was just recently finalized due to Intellectual Property Rights being split between AutoSpense and AutoCrib (Their Industrial Vending Machine Manufacturing Partner with over 15,000+ machines and lockers sold world-wide)

The reason AutoCrib is RELEVANT to Endexx (EDXC) is because they are the manufacturer for, and a partner of, our company. AutoSpense developed a Proprietary Software for tracking cannabis from "seed to sale" with other advanced technologies yet to be seen on the market. This technology is NOT limited to just Cannabis and Cannabis related products, think Pharmacies, Pain Clinics, Hospitals, Emergency Care, Etc. $$$

More interesting facts about AutoSpense's Manufacturing Partner AutoCrib:

Source: http://autocrib.com/companies-using-industrial-vending.asp

AutoCrib Client List Companies using AutoCrib industrial vending machines. AutoCrib is the world's leading provider of enterprise-level industrial vending systems. No other company has more serious enterprise-level clients then us. We are an international leader in the industrial vending industry with the broadest line of purpose-built industrial vending machines in the world. There is no other company more experienced with industrial vending on the market. We invented the first industrial vending machine and most of the innovations you see on the market today. AutoCrib is the most trusted name in industrial vending. Chances are we have worked with companies in your industry and know specifically about the inventory needs of your industry. Which makes AutoCrib a great strategic partner. Oftentimes we can even introduce you to someone near you who already implemented our industrial vending machines.

Here is a partial list of some of our clients:


Haas Automation
Toyota
ExxonMobil
Airbus
Medtronic
Alcoa
Honeywell
Caterpillar
Shell
Bimbo Bakeries
IBM
Snap-On Tools
Lufthansa
Walt Disney Imagineering
Honda Motors
National Oilwell Varco
Case New Holland
Rolls Royce
GKN
United Airlines
Halliburton
Labatt Breweries
Boston Scientific
Ryanair
Red Bull Racing
Smith & Wesson
Bell Helicopter
Trane Corporation
Boeing
Ford Motor Company
Baldor
Noble Biocare
Federal Mogul
MGM Grand
TRW Automotive
Ford Motor Company
Gates Rubber
Gulfstream Aerospace
York International
Paul Reed Smith Guitars
Wacker Corporation
Cessna
Noble Biocare
Stryker
Alaska Airlines
Trane Corporation
Goodrich
Flowserve
Eaton Corporation
All-Clad
New Jersey Transit
Briggs and Stratton
Triumph
Tinker Air Force Base (U.S. Air Force)

That's a long list of big name clients, I'd say AutoSpense is ready to go mainstream.

Just some food for thought.

http://Endexx.com
http://AutoSpense.com
http://AutoCrib.com

[TyTrades]

$PLUG breaking out

[Jaymeinnyc]

Nice I am there as well. Very exciting these past days!

[Mungyboy]

NTEK, last day to get cheapies before tomorrow shareholders meeting!

[BrazenBull]

ORGT is wanting to do it boys

[Jaymeinnyc]

drivenbypain just posted on EDXC


Thursday, June 06, 2013 10:02:58 PM
Re: None

Post # of 13589

UPDATE: 5:30pm -- Joe DeRobbio and Dispense Labs were served a cease and desist notice by a rival marijuana dispensing machine, Medbox, Inc., for violating its federal patent (7,844,363 B1). Angelique Dolan of MedBox told The Huffington Post that a lawsuit is in place.

http://www.huffingtonpost.com/2012/04/24/marijuana-vending-machine_n_1449270.html

(EDXC)

[recinvestor]

Best news for EDXC to date!
Rec

[TyTrades]

EDXC + Autospense NEWS!:

PRESS RELEASE
May 29, 2013, 4:20 p.m. EDT
Endexx Enters Into Definitive Agreement to Acquire Dispense Labs, LLC
Endexx's M3Hub and Dispense Labs' Autospense to Enhance Medical Marijuana Management Platform

CAVE CREEK, AZ, May 29, 2013 (Marketwired via COMTEX) -- Endexx Corporation (pinksheets:EDXC) announced today that it has entered into a definitive agreement to acquire Dispense Labs, LLC. Dispense Labs has a sophisticated inventory management system and client server-based dispensing machine, known as Autospense. Autospense has applications to enhance the processes necessary to provide M3Hub, a division of Endexx, with a reliable and compliant medical marijuana management solution.

"We are determined to provide the most dynamic and functional medical marijuana management platform in the industry," said Todd Davis, CEO of Endexx Corporation. "We intend to work with Dispense Labs President Joseph DeRobbio and his team to maximize the availability of Autospense, the most technologically advanced system to date that meets the needs of the medical marijuana industry and patients. Acquiring Dispense Labs was a strategic decision. As a result, we believe M3Hub is one step closer to being the dominant player in this extremely challenging market."

By incorporating sophisticated software, along with advanced safety and security measures, Autospense is designed and manufactured to dispense medical marijuana while also managing the supply chain. It also provides up-to-the-minute accounting and protects the security of the product, as well as the patient accessing the system. The high-tech machines feature compliance, tracking, accountability, inventory management and a secured client server, all of which were requirements for the M3Hub platform.

"We are pleased to be working with M3Hub and Endexx," said DeRobbio. "This acquisition gives Dispense Labs the capital resources necessary to fulfill our go-to-market strategy. The financial backing will allow us to respond to and meet industry demand for Autospense. Endexx and Dispense Labs are aligned in a shared vision of growth and sustainability. As a result, this acquisition makes our plan executable. In addition, it gives us the ability to migrate the technology into other business environments, as it is an overall solution for a variety of industries."

Moving forward, Dispense Labs will be a division of Endexx Corporation with DeRobbio as its president. Autospense, co-developed by DeRobbio, recently completed its beta-testing process. The technology solution is now being deployed into the clinical market. For more information, please call 800-316-6071.

About Dispense Labs: Comprised of forward-thinking business leaders, healthcare advocates and technical experts, Dispense Labs LLC is the innovator of Autospense, a fully automated dispensing system that mitigates problems and concerns associated with medical marijuana. Founded in 2009, the company provides innovative solutions and sound business practices in support of social, political, business, law enforcement and community interests. For more information, please call 800-316-6071 or visit www.autospense.com.

About Endexx: Endexx Corporation is a micro-cap publicly traded company, representing the interest of its shareholders and collaborating with independent software developers, scientists, engineers, and other companies to build businesses that can thrive collectively in the equity markets. Endexx's team recognizes that individually small companies with new technologies have an extremely difficult time sustaining themselves as stand-alone companies. Through our collaborative practices, individual and group skill sets are better utilized to develop technology and grow the business, while centralizing costs and eliminating redundancies.

The Endexx management team and its advisory group each have at minimum 10-50 years of experience in their respective fields. The business professionals associated with the direction of the company all have experience growing businesses, developing and implementing new technologies and running publicly traded corporations.

Endexx Corporation is ultimately structured to provide a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each individual is a shareholder and is encouraged and self-driven to be successful and contribute to the overall objective of increasing shareholder value.

[BrazenBull]

Might see a pop in erbb today after news from Colorado

[neophyte184]

I like your thought process Jayme! MWIP is a great one to load for the long haul as is EDXC. CTDT may also be one to load and hold a portion for dollar land. In fact IMO, all three have dollar potential.


Fun times coming. I have never been so excited for the summer season of trading (usually a slow time)!!

[Jaymeinnyc]

I am with you on all three of these tickers. Will be picking up more of both before launch. It is setting up to be an amazing spring and summer!

I am hoping EDX@ will blow up as I would like to double my position in MWIP.


Happy Memorial Day to all of our heroes past and present!

[neophyte184]

Yes, between MWIP and EDXC I am just beside myself! Have you taken a look at CTDT? The chart there is also exquisite and is basically where EDXC was on Thursday. I am hearing a big move is coming so it is one to check out. I would get in immediately if you can.


Enjoy your memorial day all! Our hearts are heavy today with the memories of those who protected our country on enemy soil and never made it home to be with their families afterward.

Neo

[Jaymeinnyc]

Well thank you Sir. Exciting days ahead I think!

[neophyte184]

Great to see you here Jayme! We need strong posters and your presence is the perfect fit....

[neophyte184]

It doesn't get much better than this from a technical standpoint. Now add in a strong catalyst this week, and we are talking parabolic move!

Good stuff here be doubt.

[TStarr]

Buying EDXC with FNMA profits!


Sounds like the gameplan to me.

[recinvestor]

EDXC on serious watch for next week. Fannie and Freddie back from the dead too, huge daily swings there. I saw someone say, consolidation, dip, rip, and chart resetting all happens intraday due to the liquidity. Usually takes most other stocks several days or a week to see all that in a day, lol. But it's been happening intraday multiple times. Congrats to those trading the double F's and making bank.
Rec

[ProCannabis]

Im looking forward to next weeks trading in $EDXC and $IOGA

[TyTrades]

$EDXC Annotated 3M Daily Chart: http://scharts.co/19cJCkl

Breakout Alert! 8)


And thanks, Jayme!

[TyTrades]

$EDXC - Annotated Weekly Chart: http://scharts.co/14NAFuU

Bullish Technical Breakout Chart!

[TyTrades]

Indeed! Bullish as hell! Full on technical breakout just starting up on $EDXC big news expected next week...accumulation explains this :)

[TyTrades]

$EDXC $FNMA $FMCC all rocked hard this week!

$EDXC is going to have a monumental week come next Tuesday :)

[BrazenBull]

Awesome day at edxc!!!!!

[TyTrades]

Thanks bro! We're are focused on $EDXC as you know :) Big mover in the making $$$

[Mungyboy]

Board mark! :)

[TyTrades]

$EDXC had another high volume day churning those .10's+

[nvidiaforgames]

Oh yes, CTDT was a great pick on this board

[TyTrades]

Looks ready to move on that news...no more selling with the ask lifted to .029

Got $PMBS on watch!

[Stock Rockstar]

PMBS LipiGesic® Product Shown to be Effective as Prescription Based Medications

SCHOFIELD, Wis., May 21, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced the results of clinical trials that found its over-the-counter migraine medication product, LipiGesic® M, has "robust efficacy".

With recent statistics showing nearly 39 million Americans suffering from migraine headaches, studies show that LipiGesic M provides a safe, highly effective OTC solution to migraine pain that performs as well as, if not better than, prescription migraine medications without the high cost, drowsiness, or the need for a doctor's visit.

The original double-blind, placebo-controlled clinical trial for LipiGesic M, completed in 2010, and published in the July 2011 issue of Headache: The Journal of Head and Face Pain, concluded that 64 percent of patients who used LipiGesic M found relief.

The results of a reanalysis of this same study published in Headache in February 2013 not only confirmed the original results, but Daniel Serrano, PhD stated, "...the efficacy of sublingual feverfew/ginger (LipiGesic M) appears robust..."

These results combined with Dr. Roger Cady's statement describing LipiGesic M as "...an excellent first-line therapy for very early intervention..." in the article, "Advances in Drug Development for Acute Migraine," which was published in the December 2012 issue of Drugs, a medical journal evaluating drugs and drug therapies, reaffirms LipiGesic M's effectiveness.

"With at least 39 million Americans affected by migraines and LipiGesic M currently retailing for around $19.95 per box, the revenue potential for our migraine relief product is substantial," said Russ Mitchell, CEO of PuraMed BioScience. "LipiGesic M is currently available in national retail drugstore chains, such as Walgreens and CVS/pharmacy stores. Our plan to expand to additional retail chains in the United States, as well as our International distribution, should only increase our revenue potential, and thus increase value for our shareholders."

"In addition to the expanded distribution, we anticipate an increase in consumer interest," said Mitchell. "We believe that the Affordable Care Act will drive more consumers to look for cost effective ways to manage their health. Even before the Act's full implementation, many people are currently experiencing prescription limits, higher deductibles, higher co-pays, and higher employee contributions for insurance. Since the performance of LipiGesic M, is more aptly compared to prescription formulations, rather than over-the-counter products, we believe that people currently paying $40 or more for one prescription migraine treatment will turn to LipiGesic M as a highly effective, money-saving alternative that costs approximately $5 per treatment. This only increases our revenue potential."

As of May 14, 2013, the Company currently had 37,987,165 common shares issued and outstanding.

About LipiGesic M

LipiGesic M is a sublingual, homeopathic formulation of feverfew and ginger. LipiGesic M has been clinically tested by America's leading headache experts with results published in leading medical journals stating that it is a highly effective for treatment of acute migraine pain and associated symptoms. LipiGesic does not contain aspirin, acetaminophen, or caffeine, does not cause drowsiness, and has an excellent safety profile. www.lipigesic.com

About PuraMed BioScience®, Inc

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to LipiGesic® M, PuraMed BioScience plans to launch LipiGesic® H for tension-type headaches and LipiGesic® PM, which provides a remedy for insomnia and other sleep disorders. www.puramedbioscience.com

[Jaymeinnyc]

And a lot of these folks also in CTDT. They are all doing very well for themselves.

[nvidiaforgames]

Really looking like this room us going to generate a huge following if EDXC is the main stock here!!! Hehe

[Jaymeinnyc]

Agreed. Great room!

[nvidiaforgames]

Really nice board here tytrades

[nvidiaforgames]

$EDXC time to load the cheapies!

[TyTrades]

$EDXC is going to rock hard man! Churning longer than we wanted to, but it's that much stronger now.

[ProCannabis]

page is looking good! lets get that pop in edxc tomorrow!!!!!

[TyTrades]

Sweet alert Rec, got it on watch!
ITMV Daily Chart - http://scharts.co/14nhBn1

Nice looking bottom play!

[TyTrades]

It's just getting started bro :)

[TyTrades]

I was in SKTO a couple of times, not now though.

[recinvestor]

ITMV - 3 groups confirmed buying in tomorrow. Low floater, will move fast, trade smart!
Rec

[Jaymeinnyc]

RAFF one of the MMs on SKTO. Anyone else in on that ticker?

[ProCannabis]

Love the Board Ty!!!!!

[TyTrades]

IMMY looks interesting man, hope it's making you bank. Keep an eye on both FMNA and FMCC...look to be headed for $1.50-$2 short term.

[TyTrades]

That's some huge news for PHOT bro 8)

[BrazenBull]

PHOT early morning before hours news!

[BrazenBull]

Yep I am loving that pick!! If you guys are looking for a long term play. I would highly recommend checking out imprimispharma.com ticker IMMY it's on the big board but, it might be worth looking at.